About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment Option for All CML Patients Where TFR Is The Main Goal – Con
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Jane F. Apperley
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Jane F. Apperley
9 views
October 23, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Session I: Chronic Myeloid Leukemia
19:21
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
CML: State of the Art Update
Feat.
J. Cortés
17:26
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
ELN v NCCN: Do We Have Consensus?
Feat.
C. Schiffer
14:23
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Case Studies in TFR
Feat.
D. Rea
16:17
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
When Second Generation TKIs Fail
Feat.
J. Radich
13:54
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…
Feat.
G. Saglio
15:41
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Second Generation TKIs Are The Preferred Frontline Treatment…
Feat.
J. Apperley
17:02
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Advanced CML Phase Disease: Current Management
Feat.
M. Deininger
06:09
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract CML-057: ENESTop 144-Week Update: Long-Term Treatment-…
Feat.
T. Hughes
07:46
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract CML-044: Treatment-Free Remission (TFR) in Patients wi…
Feat.
M. Mauro
12:10
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
CML: Next Questions
Feat.
T. Hughes